JP2022553379A5 - - Google Patents
Info
- Publication number
- JP2022553379A5 JP2022553379A5 JP2022523914A JP2022523914A JP2022553379A5 JP 2022553379 A5 JP2022553379 A5 JP 2022553379A5 JP 2022523914 A JP2022523914 A JP 2022523914A JP 2022523914 A JP2022523914 A JP 2022523914A JP 2022553379 A5 JP2022553379 A5 JP 2022553379A5
- Authority
- JP
- Japan
- Prior art keywords
- chain
- tcr
- sequence
- seq
- treg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201915359A GB201915359D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB1915359.2 | 2019-10-23 | ||
| PCT/GB2020/052657 WO2021079120A1 (en) | 2019-10-23 | 2020-10-22 | Engineered regulatory t cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553379A JP2022553379A (ja) | 2022-12-22 |
| JP2022553379A5 true JP2022553379A5 (enExample) | 2023-10-19 |
Family
ID=68728329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523914A Pending JP2022553379A (ja) | 2019-10-23 | 2020-10-22 | 操作された制御性ｔ細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220363733A1 (enExample) |
| EP (1) | EP4048687A1 (enExample) |
| JP (1) | JP2022553379A (enExample) |
| CN (1) | CN114641487A (enExample) |
| AU (1) | AU2020371991A1 (enExample) |
| CA (1) | CA3154615A1 (enExample) |
| GB (1) | GB201915359D0 (enExample) |
| WO (1) | WO2021079120A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7436383B2 (ja) * | 2018-04-18 | 2024-02-21 | ユーシーエル ビジネス リミテッド | 操作された調節性ｔ細胞 |
| CN119325506A (zh) * | 2022-05-05 | 2025-01-17 | 圭尔医疗有限公司 | 维持调节性t细胞的抑制活性的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| MX2019003768A (es) * | 2016-10-03 | 2019-06-24 | Juno Therapeutics Inc | Moleculas de enlace especificas de hpv. |
| JP7436383B2 (ja) * | 2018-04-18 | 2024-02-21 | ユーシーエル ビジネス リミテッド | 操作された調節性ｔ細胞 |
-
2019
- 2019-10-23 GB GB201915359A patent/GB201915359D0/en not_active Ceased
-
2020
- 2020-10-22 EP EP20800252.7A patent/EP4048687A1/en active Pending
- 2020-10-22 WO PCT/GB2020/052657 patent/WO2021079120A1/en not_active Ceased
- 2020-10-22 US US17/771,465 patent/US20220363733A1/en active Pending
- 2020-10-22 AU AU2020371991A patent/AU2020371991A1/en not_active Abandoned
- 2020-10-22 JP JP2022523914A patent/JP2022553379A/ja active Pending
- 2020-10-22 CN CN202080074667.XA patent/CN114641487A/zh active Pending
- 2020-10-22 CA CA3154615A patent/CA3154615A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021520831A5 (enExample) | ||
| KR100899970B1 (ko) | Ｔ-세포 에피토프의 동정 방법 및 감소된 면역원성을 갖는분자의 제조를 위한 용도 | |
| JP2022553540A5 (enExample) | ||
| JP2022050400A5 (enExample) | ||
| JP2021520198A5 (enExample) | ||
| JP5047996B2 (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| JP2022502371A5 (enExample) | ||
| CN105492610B (zh) | 特异性结合分子的合成文库 | |
| BR112022001923A2 (pt) | Proteína de ligação ao antígeno, ácido nucleico isolado, célula hospedeira recombinante, composição farmacêutica, método de produção da proteína de ligação ao antígeno | |
| JP2023025108A5 (enExample) | ||
| JP2019511222A5 (enExample) | ||
| JP2024522357A5 (enExample) | ||
| JP2021526816A5 (enExample) | ||
| JP2020511115A5 (enExample) | ||
| TW201827460A (zh) | 改善配對的ｔ細胞受體 | |
| IL308831A (en) | T cell receptors | |
| KR960703014A (ko) | Mhc 분자 hla-c-클론 10과 복합체를 형성하는 분리된 펩티드 및 그것의 사용(isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof) | |
| JP2022505585A5 (enExample) | ||
| CZ328895A3 (en) | Monoclonal antibody, fragment thereof, process for preparing such monoclonal antibody and pharmaceutical composition containing thereof | |
| JPWO2020059847A5 (enExample) | ||
| JP2020502996A5 (enExample) | ||
| JP2023524788A5 (enExample) | ||
| JP2023505492A5 (enExample) | ||
| JP2022553379A5 (enExample) | ||
| JP2023522799A5 (enExample) |